期刊
MEDICINA-LITHUANIA
卷 57, 期 8, 页码 -出版社
MDPI
DOI: 10.3390/medicina57080813
关键词
myeloproliferative neoplasms; cytogenetics; prognosis
Myeloproliferative neoplasms are clonal stem cell disorders characterized by clonal proliferation of myeloid cells, with cytogenetics analysis providing valuable prognostic information in the evaluation of MPNs.
Myeloproliferative neoplasms (MPNs) are clonal stem cell disorders characterized collectively by clonal proliferation of myeloid cells with variable morphologic maturity and hematopoietic efficiency. Although the natural history of these neoplasms can be measured sometimes in decades more than years, the cytogenetics analysis can offer useful information regarding the prognosis. Cytogenetics has a well-established prognostic role in acute leukemias and in myelodysplastic syndromes, where it drives the clinical decisions. NGS techniques can find adverse mutations with clear prognostic value and are currently included in the prognostic evaluation of MPNs in scores such as MIPSS, GIPSS, MIPSS-PV, and MIPSS-ET. We suggest that cytogenetics (considering its availability and relative cost) has a role regarding prognostic and therapeutic decisions.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据